Free Trial

Stericycle (NASDAQ:SRCL) Reaches New 52-Week High at $61.76

Stericycle logo with Business Services background

Stericycle, Inc. (NASDAQ:SRCL - Get Free Report)'s stock price reached a new 52-week high on Thursday . The stock traded as high as $61.76 and last traded at $61.73, with a volume of 203544 shares trading hands. The stock had previously closed at $61.67.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. StockNews.com assumed coverage on shares of Stericycle in a research note on Monday. They issued a "hold" rating for the company. Keefe, Bruyette & Woods raised their target price on Stericycle from $135.00 to $142.00 and gave the stock an "outperform" rating in a research note on Tuesday, June 4th. Truist Financial lifted their target price on Stericycle from $50.00 to $62.00 and gave the company a "hold" rating in a research report on Tuesday, June 4th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $74.00.

View Our Latest Stock Report on SRCL

Stericycle Price Performance

The company has a debt-to-equity ratio of 0.55, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a market capitalization of $5.73 billion, a price-to-earnings ratio of -280.45, a PEG ratio of 3.36 and a beta of 1.11. The stock has a 50 day moving average price of $58.86 and a two-hundred day moving average price of $54.42.


Stericycle (NASDAQ:SRCL - Get Free Report) last announced its earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, beating analysts' consensus estimates of $0.57 by $0.04. The company had revenue of $661.60 million during the quarter, compared to analysts' expectations of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. As a group, analysts expect that Stericycle, Inc. will post 2.29 EPS for the current year.

Hedge Funds Weigh In On Stericycle

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. grew its position in shares of Stericycle by 19.4% during the fourth quarter. Victory Capital Management Inc. now owns 20,487 shares of the business services provider's stock worth $1,015,000 after buying an additional 3,334 shares in the last quarter. Private Advisor Group LLC lifted its stake in Stericycle by 8.6% in the fourth quarter. Private Advisor Group LLC now owns 5,788 shares of the business services provider's stock worth $287,000 after acquiring an additional 459 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Stericycle by 2.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,084,459 shares of the business services provider's stock worth $53,746,000 after acquiring an additional 26,065 shares in the last quarter. Principal Securities Inc. acquired a new position in Stericycle during the 4th quarter worth approximately $41,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Stericycle by 10.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider's stock valued at $97,720,000 after purchasing an additional 192,045 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company's stock.

Stericycle Company Profile

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Featured Stories

Should you invest $1,000 in Stericycle right now?

Before you consider Stericycle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.

While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

SMCI Stock: Is a Rebound Coming?
FOMC’s Rate Cut Decision Could Drive Market Swings
Rate Cuts May Fuel Continued Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines